A Phase 4 interventional study of Propofol in Cognitive Dysfunction and Auditory Dysfunction, Central, sponsored by Beni-Suef University. Completed at 1 site in Egypt. Open to participants aged 20 Years to 70 Years. Per ClinicalTrials.gov, last updated 2022-05-06.
Sponsored by Beni-Suef University · Phase 4, Interventional, and Diagnostic
Perioperative hearing loss is a rarely reported phenomenon. However, it occurs more frequently than most anaesthesiologists suspect. Perioperative hearing impairment is often subclinical and may go unnoticed unless audiometry is performed.
It can be conductive or sensorineural, unilateral or bilateral, and transient or permanent. Hearing loss has been reported following virtually every type of anaesthetic technique.
The hearing mechanism may be less susceptible to acoustic trauma during general anaaesthesia. But other mechanisms are capable of causing both conductive and sensorineural hearing losses (SNHL) in the perioperative period. The aetiologies include mechanical, traumatic, noise-induced, changes in cerebrospinal fluid (CSF) pressure, embolism, pharmacologic, and other miscellaneous causes.
Stress may influence central vestibular function in health and disease either directly through the actions of glucocorticoids (cortisol and corticosterone) on ion channels and neurotransmission in the brain, or indirectly through the effects of stress-related neuroactive substances (e.g., histamine, neurosteroids) on these structures.
The auditory brainstem response (ABR) provides a good estimate of the shape of the behavioral audiogram [and is thus an extremely useful tool for studying hearing sensitivity as well as the functionality of the auditory system.
An awareness of the potential for and the causes of hearing loss during anesthesia may permit the anesthesiologist to prevent or minimize the risk of significant hearing deficit. The suggestion that this risk be discussed in the preoperative period with patients who are at high risk for perioperative hearing loss may be good medical-legal advice. Better understanding of the incidence, causes, and prognoses for perioperative hearing loss is essential for the anesthesiologist.
Much Concern has been raised about the effects of anaesthetic drugs on cognition. Postoperative cognitive dysfunction may manifest as impairment in attention, memory, language or executive functions following surgery, and can persist for weeks, months, or more with varying severity. Such post-operative cognitive dysfunction can be quite mild and only diagnosed through psychometric assessment using specific neuropsychological tests.
AIM OF THE STUDY The aim of this work is to study the possible deleterious effect of propfol versus sevoflurane on auditory and cognitive function.
Type and site of the study:
This study will be carried out at Beni-Suef university hospital, after approval by the department of Anaesthesiology, the local ethics and research committee and other involved departments, faculty of medicine, Beni-Suef University.
Date of the study:
The study will be performed starting from 1st of January 2021
Study design and population: This is a prospective randomized study that will be carried out on patients subjected to general anaesthesia.
Sampling Technique:
Patients will be randomly assigned into one of two equal groups Randomization will be carried out using a closed opaque envelope technique with the anesthetist will pick up a sealed envelope which contains a paper with the name of the group to which the patient will be randomized is written. Whichever the group written on the paper, the patient will be scheduled to it.
The patients will be subjected to the following:
Group 1:
Group 2:
Ventilation in both groups will be controlled artificially to maintain an end-tidal partial pressure of carbon dioxide of 33-35 mmHg.
At the end of surgery, neuromuscular blockade will be reversed with IV neostigmine 0.04mg/kg and atropine 0.02 mg/kg, the trachea will be extubated when the patient respond to commands, all patients will be transferred to PACU, where they receive oxygen via face mask 3-4 L/min and will be monitored.
The following parameters will be evaluated and recorded by senior anesthesiologist unaware of the study protocol:
All included patients will be subjected to the following (preoperative and 1 week postoperative):
1) Cognitive assessment:
Cognitive functions for the patients will be assessed using the following psychometric tests:
Paired Associate Learning test (PALT) (9):
Paced Auditory Serial Addition Test (PASAT) ( 10):
2) Audiological assessment:
'
3,930 studies on the registry are indexed under Cognitive Dysfunction; 1,114 are open to participants now.
This study's enrollment of 80 is above the median of 64 across 2,855 interventional studies indexed under Cognitive Dysfunction.
Browse Cognitive Dysfunction studies →Beni-Suef University is the lead sponsor of 337 studies on the registry; 114 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Maintenance of anaesthesia will be done using Propofol total intravenous anesthesia (TIVA) 6-12 mg/ kg/h by syringe pump, 100 % O2.
Drug: Propofol
Maintenance of anaesthesia will be done using sevoflorane1.5-2%, 100 % O2.
Drug: Propofol
Total intravenous inhalational anesthesia
Also known as: Sevoflurane
Audiometry
A tool for assessment of auditory function
Time frame: 1 week
Paired associate learning test
A test for assessment of cognitive function
Time frame: 1 week
Paced Auditory Serial Addition Test
A test for assessment of cognitive function
Time frame: 1 week
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in May 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Propofol